GlaxoSmithKline (GSK) is one of the world’s leading research-based pharmaceutical and healthcare companies. The company is engaged in the discovery, development, manufacturing and marketing of pharmaceutical and consumer health-related products. The company primarily operates in 120 countries and its products are sold in more than 150 countries. GSK is headquartered in Brentford, the UK and employed 99,913 people as of December 31, 2009. The company recorded revenues of £28,368 million ($44,422.3 million*) during the financial year (FY) ended December 2009, an increase of 16.5% over FY2008.The operating profit of the company was £8,425 million ($13,193 million*) during FY2009, an increase of 18% over FY2008. The net profit was £5,669 million ($8,877.3 million*) in FY2009, an increase of 20.3% over FY2008
BUSINESS DESCRIPTION
GlaxoSmithKline (GSK) is a global healthcare company specialized in the discovery, development, manufacturing and marketing of pharmaceutical and consumer health-related products.The company has operations in over 120 countries, with products being sold in more than 150 countries. Its principal R&D facilities are located in the UK, the US, Japan, Italy, Spain and Belgium. Its products are currently manufactured in about 40 countries. The major markets for the company's products are the US, the UK, France, Germany, Italy and Spain.
The company operates through two business segments: pharmaceuticals (prescription pharmaceuticals and vaccines) and consumer healthcare [over-the-counter (OTC) medicines, oral healthcare and nutritional healthcare
HISTORY
GSK traces its origins from two companies namely Glaxo and SmithKline Beecham.
Joseph Nathan founded Glaxo in 1873, as a general trading company. It manufactured its first pharmaceutical product, a vitamin D preparation called Ostelin, in 1924. Glaxo went public and was listed on the London Stock Exchange in 1942. Glaxo then entered the US pharmaceutical market in 1978.